pyrazinamide has been researched along with Submandibular Gland Diseases in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Submandibular Gland Diseases: Diseases involving the SUBMANDIBULAR GLAND.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moure, C | 1 |
| Mbuyamba, S | 1 |
| Bruniau, A | 1 |
| Gbaguidi, C | 1 |
| Testelin, S | 1 |
| Boutemy, M | 1 |
| Jounieaux, V | 1 |
| Devauchelle, B | 1 |
1 other study available for pyrazinamide and Submandibular Gland Diseases
| Article | Year |
|---|---|
[Tuberculosis of the submandibular gland: a case report].
Topics: Antitubercular Agents; Combined Modality Therapy; Diagnosis, Differential; Ethambutol; Female; Human | 2006 |